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        Introduction 
  The nonreceptor tyrosine kinase Abl is ubiquitously expressed 
and is found in both the nucleus and the cytoplasm of mamma-
lian cells. The nuclear Abl kinase is activated upon DNA damage 
to stimulate apoptosis ( Gong et al., 1999 ;  Wang, 2004 ;  Preyer et al., 
2007  ), whereas the cytoplasmic Abl is activated by growth fac-
tors, cell adhesion, and bacterial pathogens to regulate F-actin 
dynamics ( Woodring et al., 2002 ,  2003 ;  Hernandez et al., 2004 ). 
Activation of cytoplasmic Abl kinase by platelet-derived growth 
factor or EGF enhances the activation of the small GTPase Rac 
and the formation of membrane ruffl  es (  Plattner et al., 1999  ; 
  Sini et al., 2004  ). Abl-dependent activation of Rac is also ob-
served upon infection of mouse embryonic fi  broblasts with   Shi-
gella fl  exneri   (  Burton et al., 2003  ). Activated Rac-GTP stimulates 
actin polymerization through the WASP and WAVE complexes 
(  Eden et al., 2002  ). Previous studies have shown that Abl also 
stimulates F-actin microspikes and fi  lopodia through a Rac-
  independent mechanism (  Woodring et al., 2004  ;   Radha et al., 
2007 ),  which may involve the direct phosphorylation of the 
WAVE protein by Abl, leading to the stimulation of actin polymer-
ization (  Leng et al., 2005  ). 
  Although Abl kinase stimulates actin polymerization, it 
inhibits cell spreading and cell migration (  Frasca et al., 2001  ; 
  Kain and Klemke, 2001  ;   Jin and Wang, 2007  ). It has been sug-
gested that Abl kinase inhibits cell migration through tyrosine 
phosphorylation of CrkII (also known as Crk) to down-regulate 
Rac-GTP levels (  Kain and Klemke, 2001  ). One of the guanine 
nucleotide exchange factors (GEFs) for Rac is DOCK180 
(  Kiyokawa et al., 1998a  ,  b  ), which is recruited to the plasma 
membrane through an interaction between CrkII and p130Cas 
( Kiyokawa  et al., 1998a  ). Phosphorylation of CrkII at tyrosine-
221 by Abl (  Feller et al., 1994  ) disrupts the p130Cas  –  CrkII com-
plex, and may thus account for Abl-dependent down-regulation 
of Rac-GTP and the inhibition of cell migration (  Kain and 
Klemke, 2001  ). In breast cancer cells, EphB4 activation by 
ephrin-B2 causes Abl-dependent CrkII phosphorylation, which 
is correlated with an inhibition of cell migration and invasion in 
vitro and tumor growth in vivo (  Noren et al., 2006  ). Recently, 
tyrosine phosphorylation of CrkII by Abl has also been linked 
to the dorsal sequestration of Rac-GTP during cell spreading 
on fi  bronectin. As a result, Abl promotes dorsal ruffl  ing at the 
 expense  of  lamellipodia extension to restrain cell spreading 
  D
ynamic modulation of cell adhesion is integral to a 
wide range of biological processes. The small 
guanosine triphosphatase (GTPase) Rap1 is an 
important regulator of cell  –  cell and cell  –  matrix adhesions. 
We show here that induced expression of activated Abl 
tyrosine kinase reduces Rap1-GTP levels through phos-
phorylation of Tyr221 of CrkII, which disrupts interaction 
of CrkII with C3G, a guanine nucleotide exchange factor 
for Rap1. Abl-dependent down-regulation of Rap1-GTP 
causes cell rounding and detachment only when the 
Rho  –  ROCK1 pathway is also activated, for example, by 
lysophosphatidic acid (LPA). During ephrin-A1  –  induced 
retraction of PC3 prostate cancer cells, we show that endog-
enous Abl is activated and disrupts the CrkII  –  C3G com-
plex to reduce Rap1-GTP. Interestingly, ephrin-A1 –  induced 
PC3 cell retraction also requires LPA, which stimulates 
Rho to a much higher level than that is activated by 
ephrin-A1. Our results establish Rap1 as another down-
stream target of the Abl  –  CrkII signaling module and show 
that Abl  –  CrkII collaborates with Rho  –  ROCK1 to stimulate 
cell retraction.
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  Results 
  Activated Abl kinase induces 
cell detachment 
  We adopted the T-Rex system to express the activated AblPP 
protein under the control of a Tet-on promoter in HEK293 cells 
(  Hillen et al., 1983  ). The AblPP protein contains two substitu-
tions mutations, P242E and P249E (  Barila and Superti-Furga, 
1998  ), which disrupt the interaction between the Abl SH3 do-
main and its SH2 kinase linker (  Nagar et al., 2003  ) and thus lead 
to the constitutive activation of the Abl kinase (  Hantschel and 
Superti-Furga, 2004  ). We also expressed a kinase-defective Abl 
(K290H; AblKD) from the Tet-on promoter (  Fig. 1 A  ;   Welch 
and Wang, 1995  ). The expression of AblPP or AblKD was in-
duced with doxycycline (Doxy;   Fig. 1, B and E  ). As expected, 
the induced expression of AblPP led to an increase in the tyro-
sine phosphorylation of cellular proteins (  Fig. 1 B  ). Within 2 h 
of AblPP induction, the majority of cells (    80%) adopted a 
rounded morphology and detached from the dish (  Fig. 1, C and D  ). 
The cell detachment response to Doxy was blocked by imatinib, 
a small molecule inhibitor of the Abl kinase (  Fig. 1, C and D  ). 
Furthermore, Doxy did not induce the detachment of HEK293-
AblKD cells (  Fig. 1, E and F  ), nor did it induce the detach-
ment of cells expressing exogenous Abl, which is autoinhibited 
(  Jin and Wang, 2007  ). Collectively, the current results sug-
gest that the Abl  –  CrkII signaling module can target different 
downstream effectors to exert a negative effect on cell spread-
ing and cell migration. 
 The  affi  nity and avidity of integrin receptors are regu-
lated by a variety of factors in the process known as inside-out 
signaling (  Hynes, 1987  ,   2002  ;   Ginsberg et al., 2005  ). The small 
GTPase Rap1 is an important transducer of inside-out sig-
nals to activate integrins (  Bos et al., 1997  ,   2001  ). One of the 
GEFs for Rap1 is C3G, which contains several proline-rich 
sequences that associate with the N-terminal SH3 domain of 
CrkII (  Gotoh et al., 1995  ). Similar to DOCK180, C3G can be 
recruited to the plasma membrane through CrkII and p130Cas 
to stimulate Rap1-GTP (  Ichiba et al., 1999  ). We show here that 
Abl-dependent tyrosine phosphorylation of CrkII causes the 
down-regulation of Rap1-GTP and a decrease in the affi  nity 
of     1 integrin. Interestingly, the Abl-mediated reduction in 
Rap1-GTP and integrin affi  nity is not suffi  cient to cause cell de-
tachment. We have found that the Rho  –  ROCK1 pathway, acti-
vated by serum factors such as lysophosphatidic acid (LPA), 
is also required for cells to detach from the supporting matrix. 
Furthermore, we show that ephrin-A1  –  induced retraction of 
prostate cancer PC3 cells is dependent on the Abl  –  CrkII and 
Rho – ROCK  pathways. 
  Figure 1.       Induced expression of activated Abl 
caused kinase-dependent cell detachment.   
(A) Diagram of AblPP (murine type IV) and AblKD 
proteins. SH3, Src homology 3 domain; SH2, 
Src homology 2 domain; DBD, DNA-binding 
domain; FABD, F-actin binding domain. The 
kinase defective mutant (KD) was created by 
substitution of lysine 
295   with histidine residue. 
(B) AblPP can be quickly and tightly induced. 
The host HEK293-AblPP cells were treated with 
2   μ  g/ml Doxy for different lengths of time. The 
cells were then collected, whole cell lysates were 
subjected to SDS-PAGE separation, and AblPP 
protein was detected with an anti-HA antibody; 
the whole cell lysates were also immunoblotted 
with antiphosphotyrosine antibody 4G10 in a 
different gel. (C) AblPP induction causes host 
HEK293-AblPP cells to detach from the support-
ing matrix. HEK293-AblPP cells were seeded 
on coverslips and cultured overnight. AblPP 
protein was induced by Doxy for 2 h in the 
presence or absence of 5   μ  g/ml imatinib. The 
actin was stained with FITC-phalloidin. Bars, 
25   μ  m. (D) Blocking Abl kinase activity pre-
vents the detachment of HEK293-AblPP cells. 
HEK293-AblPP cells were treated with Doxy for 
different lengths of time in the absence or pres-
ence of 5   μ  g/ml imatinib. Detached cells were 
counted as described in Materials and meth-
ods. The histogram shows normalized mean 
values   ±   SEM from three independent experi-
ments. (E) The inducible expression of AblPP 
and AblKD. Cells were treated with Doxy for 
5 h. The induced AblPP and AblKD proteins 
were detected using an anti-HA antibody. 
(F) Abl kinase activity is required for detachment 
of HEK293-AblPP cells. Cells were treated with 
Doxy for 2 h. The detached cells were counted 
as described in Materials and methods. The 
histogram shows normalized mean values   ±   
SEM from three independent experiments.     713 ABI-DEPENDENT DOWN-REGULATION OF RAP1-GTP   • Huang et al. 
( Fig. 2 D ). Under the same condition, Doxy treatment did not affect 
the overall levels of     1 integrin on the cell surface or in whole 
cell lysates; in addition, Doxy treatment did not affect the num-
ber of     1 integrins that could be artifi  cially activated by Mn 
2+  
(  Fig. 2, C, E, and F  ). Furthermore, Doxy induction of AblKD 
expression did not infl  uence the reactivity of    1  integrin  with 
B44 antibody (  Fig. 2 D  ). Collectively, these results show that 
the AblPP-induced cell detachment is associated with a decrease 
in the affi  nity of    1  integrin. 
  Down-regulation of Rap1-GTP through 
Abl kinase  –  dependent disruption of the 
CrkII  –  C3G complex 
  Previous studies have documented the small GTPase Rap1 to 
play a critical role in the inside-out activation of integrins ( Caron 
et al., 2000  ;   Katagiri et al., 2000  ;   Reedquist et al., 2000  ). 
  Because AblPP expression led to a reduction in the affi  nity of    1 
integrin, we examined whether AblPP affected the levels of Rap1-
GTP. We observed a consistent threefold reduction in the levels 
of Rap1-GTP within 2 h after treatment of HEK293-AblPP 
(  Nagar et al., 2003  ) and unable to increase protein tyrosine phos-
phorylation in HEK293 cells (not depicted). These results sug-
gest that the induced expression of an activated Abl kinase acutely 
interferes with cell adhesion. 
  To determine the effect of AblPP on cell adhesion, we 
measured the number of adherent cells as a function of fi  bronectin 
concentration before or after Doxy treatment of HEK293-AblKD 
and HEK293-AblPP cells (  Fig. 2, A and B  ). The expression 
of AblKD did not affect cell adhesion to fi  bronectin (  Fig. 2 A  ). 
In contrast, the expression of AblPP shifted the fi  bronectin dose  –
  response curve to the right, indicating reduced adhesion in cells 
expressing an activated Abl kinase (  Fig. 2 B  ). The HEK293 cells 
express     1 integrin, which is a receptor for fi  bronectin (  Hynes, 
2002  ). Consistent with reduced adhesion to fi  bronectin, we found 
that induction of AblPP caused a reduction in the affi  nity of    1 
integrin (  Fig. 2, C, D, and F  ), measured by reactivity to a mono-
clonal antibody B44, which detects an epitope, named ligand-
induced binding site, present on active    1  integrin  ( Wilkins  et  al., 
1996  ). This reduction in    1  integrin  affi  nity was blocked by 
treatment of Doxy-induced HEK293-AblPP cells with imatinib 
  Figure 2.       Abl kinase  –  dependent reduction of     1 integrin afﬁ  nity for ﬁ  bronectin.   (A and B) The active Abl kinase caused a decrease in cell adhesion. 
Cells were treated with Doxy for 2 h. Cell adhesion was measured as described in Materials and methods. The data were from three technical repeats. 
The mean cell adhesion activity under 2.5   μ  g/ml ﬁ  bronectin was set as 100. (C) Induction of AblPP suppresses integrin activation. HEK293-AblPP cells 
were stained with monoclonal antibody B44, a reporter of     1 integrin activation (gray histogram), after treatment with (right) or without (left) Doxy to 
induce AblPP expression. Negative controls were stained with secondary antibody alone (neg, black outline histogram). To ensure that integrins were not 
generally deﬁ  cient in their capacity to activate, 200   μ  M Mn 
2+   was added to externally activate cell surface integrins; these positive controls were also 
stained with B44 antibody (gray outlined histogram). (D) The mean level of     1 integrin activation is lower after AblPP induction in HEK293-AblPP cells, but 
not after AblKD induction in HEK293-AblKD cells. The histogram shows normalized mean values   ±   SEM (quantiﬁ  ed from FACS) from three independent 
experiments. The integrin afﬁ  nity measurement was performed as described in Materials and methods. (E) Induction of AblPP protein did not change the 
expression level of     1 integrins. HEK293-AblPP cells were treated with Doxy for 2 h, in the absence or presence of 5   μ  g/ml imatinib.     1 integrin levels 
were measured with anti  –      1 integrin antibody P4C10 by using a nonreducing gel; anti-tubulin blot was used as loading control. (F) Induction of AblPP did 
not change total levels of     1 integrins. HEK293-AblPP cells were stained with monoclonal antibody B44 (solid histograms) or P4C10 (dotted histograms), 
in the absence (blue) or presence (red) of Doxy.     JCB • VOLUME 183 • NUMBER 4 • 2008  714
creased, and treatment with imatinib abrogated this enhanced 
CrkII phosphorylation (  Fig. 3 E  ). As expected, C3G coimmuno-
precipitated with CrkII in HEK293-AblPP cells before Doxy 
treatment (  Fig. 3 F  ). After Doxy induction, C3G was no longer 
detected in the anti-CrkII immune complex (  Fig. 3 F  ). The dis-
sociation of C3G from CrkII was blocked by imatinib, showing the 
requirement of Abl kinase activity for the inhibition of C3G  –
  CrkII interaction (  Fig. 3 F  ). To further demonstrate that tyrosine 
phosphorylation of CrkII was responsible for AblPP-induced 
down-regulation of Rap1-GTP, we expressed the CrkII-221F 
mutant in HEK293-AblPP cells. We found that the expression of 
CrkII-221F abolished AblPP-induced cell detachment (  Fig. 3 G  ) 
and that CrkII-221F expression prevented the loss of Rap1-GTP 
after AblPP induction (  Fig. 3 H  ). The coexpression with Rap1N17 
abrogated the effect of CrkII-221F and restored AblPP-induced 
cell detachment (  Fig. 3 G  ). Thus, AblPP-dependent phosphory-
lation of CrkII on Y221 causes the disruption of the CrkII  – 
C3G complex, the reduction in the levels of Rap1-GTP, and 
cell detachment. 
cells with Doxy (  Fig. 3, A and B  ). Imatinib treatment abrogated 
the reduction in Rap1-GTP levels induced by Doxy in AblPP-
expressing cells ( Fig. 3 C ). Furthermore, the reduction in Rap1-GTP 
levels did not occur upon Doxy induction of AblKD expression 
( Fig. 3 C ). Ectopic expression of the constitutively active Rap1V12 
largely blocked cell detachment caused by AblPP, whereas the 
dominant-negative Rap1N17 did not cause cell detachment with-
out AblPP ( Fig. 3 D ). These results suggest that the down-regulation 
of Rap1-GTP by AblPP is necessary but may not be suffi  cient to 
cause cell detachment. 
  One of the GEFs for Rap1 is C3G (  Gotoh et al., 1995  ). 
The C3G protein binds to the N-terminal SH3 domain of the 
CrkII adaptor protein (  Feller et al., 1994  ;   Matsuda et al., 1994  ;   Ren 
et al., 1994  ;   Tanaka et al., 1994  ); and formation of the CrkII  –
  C3G complex leads to the stimulation of Rap1-GTP (  Ohba et al., 
2001  ). Because CrkII is a substrate of the Abl kinase (  Feller, 
2001  ), we tested whether AblPP could disrupt the CrkII  –  C3G 
complex. Upon induction of AblPP, phosphorylation of the 
endogenous CrkII protein at tyrosine-221 was signifi  cantly in-
  Figure 3.       Abl kinase  –  dependent down-regulation of Rap1 through CrkII  –  C3G.   (A) The active Abl kinase caused a decrease in the levels of Rap1-GTP. 
HEK293-AblPP cells were treated with Doxy for 2 h. Rap1-GTP levels were measured as described in Materials and methods. (B) The mean level of 
Rap1-GTP dropped after AblPP induction. The histogram shows normalized mean values   ±   SEM (quantiﬁ  ed from immunoblots) from three independent 
experiments. (C) Abl kinase activity is required for down-regulation of Rap1-GTP levels. Cells were treated with Doxy for 2 h in the absence or presence 
of imatinib. Rap1-GTP levels were measured as described in Materials and methods. (D) A constitutively active Rap1 mutant (Rap1V12) abrogated 
AblPP-induced cell detachment. HEK293-AblPP cells were transfected with 2   μ  g GFP, Rap1N17, or Rap1V12 plasmids for 48 h. The cells were then 
treated with Doxy for 2 h. Detached cells were counted as described in Materials and methods. (E) Active Abl kinase phosphorylates CrkII on Tyr221. 
HEK293-AblPP cells were treated with Doxy for 2 h. The CrkII immunoprecipitates were probed with an antibody recognizing phosphorylated Tyr221 
of CrkII and then reprobed with an antibody to CrkII. (F) CrkII forms a complex with C3G and this complex was disrupted by AblPP induction. HEK293-
AblPP cells were treated with Doxy for 2 h. Western blots of CrkII immunoprecipitates were probed with anti-CrkII or anti-C3G antibodies. Whole cell 
lysates were probed with the same antibodies to be used as loading controls. (G) CrkII-221F abrogated AblPP-induced detachment of HEK293-AblPP 
cells. HEK293-AblPP cells were transfected with 2   μ  g CrkII, CrkII-221F, or CrkII-221F plus Rap1N17 plasmids for 48 h. The cells were then subjected 
to treatment with Doxy for 2 h. Detached cells were counted as described in Materials and methods. The histogram shows normalized mean values   ±   
SEM from three independent experiments. (H) CrkII-221F abrogated AblPP-induced decrease of Rap1-GTP levels. HEK293-AblPP cells were transfected 
with 2   μ  g of vector, CrkII, or CrkII-221F plasmids for 48 h. The cells were then subjected to Doxy treatment for 2 h. Rap1-GTP levels were measured as 
described in Materials and methods.     715 ABI-DEPENDENT DOWN-REGULATION OF RAP1-GTP   • Huang et al. 
with our hypothesis, we found that neither LPA nor Doxy alone 
induced rounding and detachment of the HEK293-AblPP cells, 
but the combined treatment (LPA plus Doxy) caused cell round-
ing and detachment in serum-free media (  Fig. 4, C and D  ). 
  To further demonstrate the requirement of Rho, we ex-
pressed a constitutively active RhoV14 or a dominant-negative 
RhoN19 in HEK293-AblPP cells and monitored cell detach-
ment after AblPP induction. Cells expressing RhoV14 underwent 
detachment after AblPP induction in the absence of LPA or 
  serum (  Fig. 4 E  ), showing that constitutively active Rho could 
supplant the LPA or serum requirement. Furthermore, the domi-
nant-negative RhoN19 largely, if not completely, abrogated cell 
detachment even when AblPP was induced in the presence of 
LPA or serum ( Fig. 4 E ). An important downstream effector of Rho 
  Requirement of Rho and ROCK1 in 
cell detachment 
  During the course of these studies, we noticed that Doxy treat-
ment did not cause cell detachment in serum-free media (  Fig. 4, 
A and B  ), despite similar levels of induction of the AblPP pro-
tein (  Fig. 4 A  ). We postulated that cell detachment might also 
require contractility that is stimulated by serum factors. It is 
well established that actin-myosin  –  based cellular contractility 
is stimulated by the Rho-GTP  –  activated protein kinase ROCK1 
(  Kimura et al., 1996  ,   1998  ) and that the Rho  –  ROCK1 pathway 
is activated by mitogenic factors such as LPA (  Moolenaar, 1995  ). 
LPA binds a G protein  –  coupled receptor to activate heterotri-
meric G proteins (G     12/13  ), leading to the activation of the Rho  –
 ROCK1 pathway ( Hart et al., 1998 ;  Kozasa et al., 1998 ). Consistent 
  Figure 4.       Requirement for the Rho  –  ROCK1 pathway in cell detachment.   (A, left) Expression of AblPP induced the HEK293-AblPP cells to detach from sup-
porting matrix in complete media but not in serum-free media. HEK293-AblPP cells were cultured overnight; the media were then changed to fresh DME 
supplemented with 10 or 0.1% of serum. The cells were then treated with Doxy for 2 h. Cells were ﬁ  xed and actin was stained with FITC-phalloidin. Bars, 
25   μ  m. (right) The whole cell lysates from different conditions were subjected to SDS-PAGE separation and AblPP protein was detected with an anti-HA 
antibody. (B) The mean level of cell detachment of HEK293-AblPP cells in DME, supplemented with 10 or 0.1% of serum. The histogram shows normalized 
mean values   ±   SEM from three independent experiments. (C) Activated Abl and LPA were both required to induce the host HEK293-AblPP cells to detach. 
HEK293-AblPP cells were treated with Doxy for 2 h in serum-free media, in the presence or absence of 1   μ  g/ml LPA. Cells were then ﬁ  xed and actin was 
stained with FITC-phalloidin. Bars, 25   μ  m. (D) The mean level of cell detachment of HEK293-AblPP cells in fresh DME, treated with or without Doxy, in the 
presence or absence of LPA. The histogram shows normalized mean values   ±   SEM from three independent experiments. (E) Rho activity is required for 
activated Abl to induce cells to detach. HEK293-AblPP cells were transfected with the constitutively activated RhoV14 or the dominant-negative RhoN19 
constructs for 48 h. Cells were then treated with Doxy for 2 h. The detached cells were counted as described in Materials and methods. The histogram 
shows normalized mean values   ±   SEM from three independent experiments. (F) A speciﬁ  c inhibitor of ROCK1, Y27632, can completely block AblPP-
  induced HEK293-AblPP cell detachment. HEK293-AblPP cells were pretreated with or without 20 nM Y27632 for 1 h and then treated with Doxy for 2 h. 
The detached cells were counted as described in Materials and methods. (G) Knockdown of ROCK1. HEK293-AblPP cells were transfected with control 
siRNA   (LacZ)   or   ROCK1   siRNA. 48 h after transfection, both pools of the cells were treated with or without Doxy for 2 h. Whole cell lysates were then 
collected and probed with anti-ROCK1 antibodies; anti-tubulin blot was used as a loading control. (H) Knockdown of ROCK1 inhibited AblPP-induced 
HEK293-AblPP cell detachment. 48 h after transfection with the indicated siRNA, HEK293-AblPP cells were treated with Doxy for 2 h. The detached cells 
were counted as described in Materials and methods. The histogram shows normalized mean values   ±   SEM from three independent experiments.     JCB • VOLUME 183 • NUMBER 4 • 2008  716
Rho  –  ROCK1 pathway. A previous paper has shown that stimu-
lation of PC3 prostate cancer cells with ephrin-A1 reduces their 
adhesion to fi  bronectin (  Miao et al., 2000  ). Ephrin-A1 is shown 
to activate the EphA2 receptor tyrosine kinase in PC3 cells (  Miao 
et al., 2000 ). Previous studies have also shown that Abl is a down-
stream effector of activated Eph family of tyrosine kinase recep-
tors and that stimulation of EphB4 receptor in breast cancer cells 
leads to Abl-dependent tyrosine phosphorylation of CrkII at 
Y221 (  Harbott and Nobes, 2005  ;   Pasquale, 2005  ,   2008  ;   Noren 
et al., 2006  ). We therefore tested if Abl kinase plays a role in 
ephrin-A1  –  induced detachment of PC3 cells. 
  Stimulation of PC3 cells with Fc-conjugated ephrin-A1 
induced a rapid and transient tyrosine phosphorylation of the 
endogenous Abl protein, peaking at 10 min and decaying by 30 min 
(  Fig. 6, A and B  ). Imatinib reduced the tyrosine phosphorylation 
of the Abl protein, indicating autophosphorylation (  Fig. 6 A  ). 
The addition of Fc-ephrin-A1 also induced a rapid and transient 
retraction of PC3 cells, in keeping with previous results (  Miao 
et al., 2000  ;   Fig. 6, C and D  ). Interestingly, imatinib reduced 
this retraction response by about threefold (  Fig. 6, C and D  ), 
suggesting a role for Abl kinase in Fc-ephrin-A1  –  induced cell 
rounding and detachment. Similar to the effect of AblPP in HEK293 
cells, activation of the endogenous Abl kinase by Fc-ephrin-A1 
caused a reduction in the levels of Rap1-GTP, and this effect 
was blocked by imatinib (  Fig. 6 E  ). To further demonstrate the 
requirement of Abl, we stably expressed a lentiviral Abl small 
hairpin RNA (shRNA) or control shRNA in PC3 cells ( Fig. 6 F  ). 
Treatment with Fc-ephrin-A1 reduced the B44 reactivity of    1 
integrin in PC3 cells, and this reduction was abolished in Abl 
knocked down PC3 cells (  Fig. 6 G  ). In PC3 cells, stimulation 
with Fc-ephrin-A1 disrupted the C3G coimmunoprecipitation 
with CrkII (  Fig. 6 H  , left panels). The disruption of the C3G  –  CrkII 
complex was not observed in Fc-ephrin-A1  –  stimulated PC3 
cells transduced with the Abl-shRNA (  Fig. 6 H  , right panels). 
These results show that Fc-ephrin-A1 activates Abl tyrosine 
  kinase in PC3 cells and that Abl is required for the reduced 
  adhesion, the down-regulation of Rap1-GTP, and the disruption 
of the CrkII  –  C3G complex. 
  We also tested the requirement of Rho and ROCK1 in 
Fc-ephrin-A1  –  induced PC3 cell retraction. It has been re-
ported that activated Eph receptors can stimulate Rho-GTP 
( Shamah et al., 2001 ;  Sahin et al., 2005 ) and that the Rho – ROCK1 
in contractility is the ROCK1 kinase (  Kimura et al., 1996  ,   1998  ), 
which can be inhibited by the compound Y27362 (  Fujisawa 
et al., 1996  ). We found that treatment of HEK293-AblPP cells 
with Y27362 completely blocked the Doxy-induced cell detach-
ment (  Fig. 4 F  ). We also knocked down ROCK1 in HEK293-
AblPP cells with siRNA and found that the reduction in ROCK1 
signifi  cantly lowered the percentage of detached cells after 
AblPP induction (  Fig. 4, G and H  ). These data provide further 
evidence that the Rho  –  ROCK1 pathway is required for AblPP-
induced cell detachment. 
  Inhibition of Rap1 and activation of Rho are 
independent pathways in cell detachment 
  Results shown in   Figs. 3 and 4   suggest down-regulation of 
Rap1-GTP and up-regulation of Rho-GTP are both required for 
cell detachment after the induced expression of AblPP. We there-
fore tested whether AblPP could directly affect the activity of Rho 
and whether LPA could directly affect the activity of Rap1. 
As shown in   Fig. 5 A  , Doxy induction of AblPP caused similar 
reductions in the Rap1-GTP levels in the absence or presence 
of serum or LPA. In contrast, LPA did not affect the levels of 
Rap1-GTP when AblPP was not induced. These results show that 
serum factors are dispensable for the inhibition of Rap1 by AblPP. 
In contrast, induced expression of AblPP did not increase the 
levels of Rho-GTP, either in the presence or the absence of 
  serum. The activation of Rho-GTP by LPA was similarly un-
affected by Doxy induction of AblPP (  Fig. 5 B  ). These results 
show that AblPP does not infl  uence Rho-GTP levels. Given 
the previous fi  ndings that CrkII phosphorylation is associated 
with the down-regulation of Rac-GTP (  Kain and Klemke, 2001  ), 
we also measured the levels of Rac-GTP and found that neither 
AblPP induction nor LPA reduced the levels of Rac-GTP in this 
experimental system (  Fig. 5 C  ). Collectively, these data show 
that down-regulation of Rap1-GTP by activated Abl kinase and 
up-regulation of Rho-GTP by LPA are independent pathways, 
and both are required to cause cell detachment. 
  Requirement of Abl kinase and LPA 
in ephrin-induced cell rounding 
  The aforementioned experiments with the HEK293-AblPP cells 
have led to the conclusion that acute activation of Abl kinase 
can cause cell rounding and detachment in conjunction with the 
  Figure 5.       Down-regulation of Rap1-GTP by activated Abl kinase is independent of Rho-GTP up-regulation by LPA.   (A and B) HEK293-AblPP cells were 
cultured overnight and were kept in complete media (+ serum) or changed to fresh DME (     serum) for 2 h. The cells were then treated with or without 
Doxy for 2 h. The cells in DME (lanes 5  –  8) were also subject to LPA treatment (lanes 6 and 8) for 5 min, in the presence (lanes 7 and 8) or absence (lanes 
5 and 6) of AblPP by treating with Doxy for 2 h. Rap1-GTP (A) and Rho-GTP (B) were then pulled down from whole cell lysates as described in Materials 
and methods. Whole cell lysates were also resolved and immunoblotted with antibodies to Rap1 or Rho as loading controls. (C) HEK293-AblPP cells were 
cultured overnight and were then changed to fresh DME for 2 h. The cells were then treated with or without Doxy for 2 h. After that, cells were treated with 
or without LPA for 5 min. Rac-GTP was pulled down from whole cell lysates as described in Materials and methods. Whole cell lysates were also resolved 
and immunoblotted with antibody to Rac as loading controls.     717 ABI-DEPENDENT DOWN-REGULATION OF RAP1-GTP   • Huang et al. 
concentrations of Fc-ephrin-A1 might have caused receptor 
down-regulation and thus limited the levels of Rho-GTP, we 
tested lower concentrations and observed a similar require-
ment for LPA in cell detachment irrespective of Fc-ephrin-A1 
concentrations (  Fig. 7 F  ). Thus, in PC3 cells, Fc-ephrin-A1 
alone was suffi  cient to activate Abl kinase and to reduce Rap1-
GTP but not suffi  cient to activate the Rho  –  ROCK1 pathway 
to a level that can induce cell rounding. To further demon-
strate the separation of the Abl  –  Rap1 and the Rho  –  ROCK1 
pathways, we show that the ROCK1 inhibitor does not block 
Fc-ephrin-A1  –  induced disruption of the CrkII  –  C3G complex 
(  Fig. 7 G  ). Therefore, the two independent pathways shown to 
be required for the detachment of HEK293-AblPP cells were 
also required for the Fc-ephrin-A1  –  induced retraction of PC3 
cells (  Fig. 8  ). 
pathway is required for Eph-induced cell retraction (  Wahl et al., 
2000  ;   Lawrenson et al., 2002  ). Consistently, we found that the 
ROCK1 kinase inhibitor (Y27632) completely blocked the 
rounding response to Fc-ephrin-A1 in PC3 cells ( Fig. 7, A and B ). 
However, we also found that Fc-ephrin-A1  –  induced cell round-
ing was signifi  cantly reduced in serum-free media and it could 
be restored by the addition of LPA (  Fig. 7, C and D  ). We com-
pared the effects of Fc-ephrin-A1 and LPA on the levels of 
Rho-GTP in serum-starved PC3 cells and found that Fc-ephrin-
A1 caused a transient activation of Rho-GTP at a level that 
was much lower than that stimulated by LPA (  Fig. 7 E  ). 
Collectively, results in   Fig. 7 (A  –  E)   suggest that Eph-dependent 
activation of Rho is not suffi  cient and that the additional simu-
lation of the Rho  –  ROCK1 pathway by LPA is also necessary 
to induce cell retraction. To rule out the possibility that high 
  Figure 6.       Abl  –  Rap1 pathway is required 
in ephrin-A1  –  induced PC3 cell detachment.   
(A) Endogenous c-Abl was phosphorylated 
within 15 min after treatment of PC3 cells with 
Fc-ephrin-A1. After 15 min of treatment, either 
in the absence or presence of 5   μ  g/ml imatinib, 
PC3 cells were collected. Western blots of Abl 
immunoprecipitates were probed with the anti-
phosphotyrosine antibody 4G10. Whole cell 
lysates were probed with anti-Abl antibody as 
loading control. (B) Time course experiment of 
c-Abl phosphorylation after treatment of PC3 
cells with Fc-ephrin-A1. PC3 cells were treated 
with Fc-ephrin-A1 for different lengths of time. 
Western blots of Abl immunoprecipitates were 
probed with the antiphosphotyrosine antibody 
4G10. (C) Imatinib partially blocked ephrin-
A1  –  induced PC3 cell detachment. PC3 cells 
were treated with Fc-ephrin-A1 for 10 min, in 
the absence or presence of imatinib. Cells were 
then ﬁ   xed and actin was stained with FITC-
phalloidin. Bars, 25   μ  m. (D) The mean level of 
detached PC3 cells was reduced by pretreat-
ment with imatinib in PC3 cells. The histogram 
shows normalized mean values   ±   SEM from 
three independent experiments. (E) Ephrin-A1 
treatment led to a reduction in Rap1-GTP 
levels, but could be rescued by pretreatment 
with imatinib. PC3 cells were subjected to Fc-
ephrin-A1 treatment for 10 min, and Rap1-GTP 
was pulled down and detected as described 
in Materials and methods. (F) Generation of 
PC3-Abl-shRNA cells. PC3 cells were infected 
by lentiviral shRNA construct or the control vec-
tor. Whole cell lysates from the selected cells 
were subjected to SDS-PAGE separation and 
Abl protein was detected with an anti-Abl anti-
body. (G) Knockdown of endogenous c-Abl 
in PC3 cells prevents     1 integrin afﬁ  nity  de-
crease after ephrin-A1 treatment. PC3 and the 
PC3-Abl-shRNA cells were subjected to Fc-
ephrin-A1 treatment for 10 min (left and middle, 
red) and compared with untreated controls (left 
and middle, blue) for staining with the active 
integrin-speciﬁ  c antibody B44. Although ephrin-
A1 treatment selectively decreased integrin 
activation in cells expressing c-Abl, the overall 
level of integrin was the same in cells regard-
less of c-Abl expression (right, red vs. blue). 
(H) Knockdown of Abl in PC3 cells prevents 
CrkII  –  C3G complex dissociation after ephrin-A1 treatment. PC3 cells and PC3-Abl-shRNA cells were treated with Fc-ephrin-A1 for 10 min, in the absence 
or presence of imatinib. Western blots of CrkII immunoprecipitates were probed with anti-CrkII or anti-C3G antibodies. Whole cell lysates were probed 
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reduction of Rap1-GTP in neurons or colon cancer cells, re-
spectively (  Riedl et al., 2005  ;   Richter et al., 2007  ). In neurons, 
the ephrin-A1  –  induced down-regulation of Rap1-GTP involves 
SPAR, a Rap1-GAP that is recruited to the EphA4 receptor 
(  Richter et al., 2007  ). The mechanism of Rap1-GTP down-
  regulation in colon cancer cells was not determined (  Riedl et al., 
2005  ). In breast cancer cells, it has been shown that ephrin-B2 
activates Abl to phosphorylate CrkII at tyrosine-221 (  Noren 
et al., 2006  ). Our results show that CrkII tyrosine phosphory-
lation contributes to the reduction of Rap1-GTP, via the disso-
ciation of C3G from pY221  –  CrkII. Collectively, these results 
support the conclusion that reduction of Rap1-GTP is an impor-
tant downstream effect of Eph family receptor activation and 
that this reduction can be achieved through the Abl  –  CrkII path-
way described here as well as the direct recruitment of a Rap1-
GAP to the activated receptor (  Richter et al., 2007  ). 
  The adaptor protein CrkII forms a complex with C3G 
(  Tanaka et al., 1994  ;   Feller, 2001  ), which is a GEF for Rap1 
(  Reedquist et al., 2000  ). The SH2 domain of CrkII binds to 
  Discussion 
  Abl-dependent reduction of Rap1-GTP 
downstream of Eph 
  We show here that activation of Abl tyrosine kinase causes re-
duction in the levels of Rap1-GTP through CrkII tyrosine phos-
phorylation and the disruption of the CrkII – C3G complex ( Figs. 
3, 5, and 6  ). Consistent with the function of Rap1-GTP as an 
activator of integrins (  Reedquist et al., 2000  ;   Bos et al., 2001  ; 
  Bertoni et al., 2002  ), Abl-dependent reduction of Rap1-GTP 
leads to a reduction in the affi  nity of    1  integrin  ( Figs.  2  and  6 ). 
We further show that Fc-ephrin-A1 activates Abl kinase and 
causes Abl-dependent disruption of the CrkII  –  C3G complex 
and the down-regulation of Rap1-GTP in PC3 prostate cancer 
cells (  Fig. 6  ). This Abl-dependent pathway is likely to contrib-
ute to the previously reported interference of cell adhesion by 
Fc-ephrin-A1 in PC3 cells (  Miao et al., 2000  ). 
  Two recent reports have shown that activation of EphA4 
by ephrin-A1 or activation of EphB2 by ephrin-B1 caused the 
  Figure 7.       Rho  –  ROCK1 pathway is also required in ephrin-A1-induced PC3 cell detachment.   (A) ROCK1 activity was required for ephrin-A1  –  induced 
PC3 cell detachment. PC3 cells were treated with Fc-ephrin-A1 for 10 min, either in the absence or presence of 20 nM Y27632. Cells were then ﬁ  xed 
and actin was stained with FITC-phalloidin. Bars, 25   μ  m. (B) Y27632 blocked ephrin-A1  –  induced PC3 cell detachment. The histogram shows normalized 
mean values   ±   SEM from three independent experiments. (C) LPA restored PC3 cell detachment induced by ephrin-A1 in serum-free media. PC3 cells were 
cultured overnight in 0.1% serum and changed to fresh media without serum for 4 h. Cells were then treated with Fc-ephrin-A1 for 15 min, in the absence 
or presence of 1   μ  g/ml LPA. Cells were then ﬁ  xed and actin was stained with FITC-phalloidin. Bars, 25   μ  m. (D) The mean level of cell detachment of PC3 
cells in serum-free media after Fc-ephrin-A1 treatment, in the presence or absence of LPA. The histogram shows normalized mean values   ±   SEM from three 
independent experiments. (E) Activation of Rho by ephrin-A1 or LPA. PC3 cells were cultured overnight in 0.1% serum and changed to fresh media without 
serum for 4 h. Cells were then treated with Fc-ephrin-A1 or LPA. At the indicated time (in minutes), cells were harvested and Rho-GTP was measured as de-
scribed in Materials and methods. (F) The mean level of cell detachment of PC3 cells after different concentrations of Fc-ephrin-A1 treatment. PC3 cells were 
cultured overnight in media with 0.1% serum and changed to fresh media without serum for 4 h and then treated with the indicated concentrations of 
Fc-ephrin-A1 for 15 min, in the absence or presence of 1   μ  g/ml LPA. Rounded cells were counted. The histogram shows normalized mean values   ±   SEM from 
three independent experiments. (G) ROCK1 inhibitor does not interfere with the CrkII  –  C3G complex dissociation after ephrin-A1 treatment. Exponentially 
growing PC3 cells were treated with Fc-ephrin-A1 for 10 min, in the absence or presence of 20 nM Y27632. Western blots of CrkII immunoprecipitates 
were probed with anti-CrkII or anti-C3G antibodies. Whole cell lysates were probed with the same antibodies as loading controls.     719 ABI-DEPENDENT DOWN-REGULATION OF RAP1-GTP   • Huang et al. 
tion of C3G from CrkII in PC3 cells to a direct competition by 
Abl, despite the fact that the dissociation of C3G is dependent 
on Abl in PC3 cells. It is conceivable that the pY221  –  CrkII pro-
tein, with the exposure of the latent SH3-binding site, may par-
ticipate in an alternative protein  –  protein interaction to displace 
C3G and thus contribute to the reduction of Rap1-GTP. 
  Cell detachment as a result of Abl 
activation requires Rho activity 
  Although Abl kinase reduces the affi  nity of     1 integrin, it is not 
suffi  cient to cause cells to detach from the supporting matrix 
(  Fig. 4  ). We show that the activities of the small GTPase Rho 
and its downstream effector ROCK1 kinase are also required for 
cells to round up and detach (  Fig. 4  ). Induced expression of AblPP 
does not activate the Rho  –  ROCK1 pathway in the absence of 
serum factors (  Fig. 5  ), nor does it affect myosin light chain 
phosphorylation (not depicted). Instead, activation of Rho by 
serum factors such as LPA is required to collaborate with Abl 
kinase to cause cell detachment (  Fig. 4  ). Because serum or LPA 
is not required for AblPP to reduce Rap1-GTP (  Fig. 5  ), our 
  results suggest that cell detachment occurs under conditions 
of Rap1-GTP down-regulation in combination with high levels 
of Rho-GTP (  Fig. 8  ). 
  Interestingly, we show that serum or LPA also promotes 
Fc-ephrin-A1  –  induced rounding of PC3 prostate cancer cells 
(  Fig. 7  ). Activation of the Eph family of receptors has been linked 
to the stimulation of Rho through several pathways in neurons and 
cancer cells (  Wahl et al., 2000  ;   Shamah et al., 2001  ;   Lawrenson 
et al., 2002  ;   Sahin et al., 2005  ;   Parri et al., 2007  ;   Fang et al., 
2008  ). Those results are consistent with our fi  nding that Fc-
ephrin-A1 stimulation of PC3 cells caused a transient increase 
in Rho-GTP levels. However, we also show that the increase in 
Rho-GTP induced by Fc-ephrin-A1 in serum-free media is not 
suffi  cient to cause cell retraction. Instead, the additional and stron-
ger activation of Rho-GTP by serum factors such as LPA is re-
quired for PC3 cells to retract. Collectively, the current literature 
and the results described here suggest that the limited stimula-
tion of Rho-GTP by an activated Eph receptor may be suffi  cient 
tyrosine-phosphorylated p130Cas (  Kain et al., 2003  ;   Holcomb 
et al., 2006  ), allowing for the recruitment of CrkII  –  C3G to the 
plasma membrane and the activation of membrane-bound Rap1. 
Thus, tyrosine phosphorylation of p130Cas can lead to the acti-
vation of Rap1-GTP (  Gotoh et al., 2000  ;   Sakakibara et al., 2002  ). 
Previous studies have demonstrated that Y221 phosphorylation 
of CrkII induces an intramolecular interaction between pY221 
and the SH2 domain of CrkII (  Rosen et al., 1995  ), thus causing the 
dissociation of CrkII from pTyr-p130Cas (  Kain and Klemke, 
2001 ). However, this mechanism cannot explain the dissociation 
of C3G, which binds the CrkII SH3 domain (  Knudsen et al., 1995 ; 
 Wu et al., 1995 ). Previous studies have shown that pY221 – CrkII 
does not form a complex with C3G (  Okada et al., 1998  ;   Feller, 
2001  ), which is consistent with our results that Abl-dependent 
phosphorylation of CrkII at Y221 leads to the disruption of the 
C3G  –  CrkII complex. It thus appears that Y221 phosphorylation 
not only blocks the CrkII SH2 domain but also affects the abil-
ity of CrkII SH3 domain to bind proteins such as C3G (  Feller, 
2001  ). The mechanism underlying phosphorylation-mediated 
disruption of the CrkII  –  C3G complex is presently unclear. 
A possible clue to how pY221 may disrupt the CrkII – C3G complex 
is provided by previous fi  ndings that the pY221-SH2 intramo-
lecular interaction can activate a latent SH3-binding site in the 
CrkII SH2 domain (  Anafi   et al., 1996  ;   Donaldson et al., 2002  ). 
Perhaps this pY221-induced latent binding site may recruit an-
other protein to cause the dissociation of C3G. With the over-
produced AblPP protein, we have observed a kinase-dependent 
formation of the AblPP  –  CrkII complex upon Doxy induction 
of HEK293-AblPP cells (Fig. S1 A, available at http://www.jcb
.org/cgi/content/full/jcb.200801192/DC1), correlating with the 
dissociation of C3G (  Fig. 3 F  ). Because the latent SH3-binding 
site in the CrkII SH2 domain can bind to the Abl SH3 domain 
( Anafi   et al., 1996  ;   Donaldson et al., 2002  ), the overproduced 
AblPP protein itself appeared to bind to pY221  –  Crk and may 
thus contributing to the dissociation of C3G. However, we did 
not detect a stable CrkII  –  Abl complex in PC3 cells after Fc-
ephrin-A1  –  induced activation of the endogenous Abl kinase 
(unpublished data). Therefore, we cannot attribute the dissocia-
  Figure 8.       Two parallel pathways are required 
for Abl-dependent cell detachment.   Activation 
of Abl kinase by ephrin-A1 disrupts the CrkII  –
  C3G complex to lower the levels of Rap1-GTP 
and thus reduces the afﬁ  nity of     1 integrin. 
In parallel, serum factors such as LPA strongly 
activate the Rho  –  ROCK1 pathway to stimulate 
cellular contractility. The combination of a re-
duced level of cell adhesion and a high level 
of cellular contractility causes cell detachment 
from the extracellular matrix.     JCB • VOLUME 183 • NUMBER 4 • 2008  720
effect of EphB4 on breast cancer cell migration and invasion 
has been linked to the activation of Abl and the phosphorylation 
of CrkII (  Noren et al., 2006  ). This conclusion is consistent with 
the inhibitory role of Abl in cell migration. However, other studies 
have found a positive correlation between the Abl kinase activ-
ity and the metastatic potential of breast cancer cells (  Srinivasan 
and Plattner, 2006  ;   Srinivasan et al., 2007  ). Metastasis is a com-
plex process that requires tumor cells to escape from the tissue 
of origin, travel through the circulations, and colonize remote 
tissue sites (  Chambers et al., 2000  ). Because activated Abl ki-
nase inhibits cell migration (  Woodring et al., 2003  ), it can inter-
fere with tumor cell migration to distant sites; at the same time 
down-regulation of Rap1-GTP by activated Abl kinase may 
promote dissociation of tumor cells from the parent tissue. As a 
result, pharmacological inhibitors of the Abl kinase may block 
tumor cell escape from the tissue of origin but run the risk of 
promoting tumor migration to distant sites. 
  Materials and methods 
  Generation of inducible cell lines 
  HEK293-AblPP, HEK293-Abl, and HEK293-AblKD cell lines were gener-
ated by using the T-Rex system (Invitrogen). In brief, the   AblPP  ,   Abl  , or 
  AblKD   genes were cloned into the pcDNA5-FRT-TO plasmid; an HA 
tag was also attached at the C terminus of   AblPP  ,   Abl  , or   AblKD   genes. 
pcDNA5-FRT-TO-AblPP, pcDNA5-FRT-TO-Abl, or pcDNA5-FRT-TO-AblKD, 
together with the Flp recombinase expression vector pOG44 were cotrans-
fected into the HEK293-FRT cell line, which contains a single integrated FLP 
recombination target site and stably expresses the Tet repressor. The cells 
were then subjected to selection with 200   μ  g/ml of hygromycin and 
15   μ  g/ml of blasticidin for 15 d. Single clones were then picked, ampliﬁ  ed, 
and screened for induction efﬁ  ciency. 
  Cell culture 
  The inducible cell lines were cultured in DME containing 10% FBS, 100 U 
penicillin/streptomycin, and 0.05%     -mercaptoethanol. Cells were rou-
tinely treated with 2   μ  g/ml Doxy at 37  °  C for protein induction. The PC3 
cell line was cultured in RPMI 1640 media containing 10% FBS and 100 U 
penicillin/streptomycin. 
  Antibodies, chemicals, and plasmids 
  Mouse anti-Abl monoclonal antibody 8E9 was generated in our labora-
tory; mouse anti-HA was obtained from Covance; rabbit anti-ROCK1, rab-
bit anti-Rap1, and rabbit anti-C3G antibodies were purchased from Santa 
Cruz Biotechnology, Inc.; rabbit anti-Rho and rabbit anti  –  phospho-CrkII 
(Tyr 
221  ) were obtained from Cell Signaling Technology; mouse anti  –      1 in-
tegrin antibody P4C10 and the conformation-speciﬁ  c anti  –      1 integrin anti-
body B44 were obtained from Millipore; mouse anti-CrkII was obtained 
from BD; mouse anti-actin, Doxy, hygromycin, blasticidin, and LPA were 
obtained from Sigma-Aldrich; imatinib was obtained from Novartis; and 
Fc-ephrin-A1 was obtained from R  &  D systems. The pcDNA3-Rap1V14 and 
pGEX-RalRBD plasmids were obtained from S. Shattil (University of Califor-
nia, San Diego [UCSD], La Jolla, CA); the pCDNA3-RhoV14 and -RhoN19 
constructs were obtained from M. Ginsberg (UCSD); and the pcDNA3-
CrkII221F construct was obtained from E. Pasquale (Burnham Institute for 
Medical Research, La Jolla, CA). 
  Immunoblotting and immunoprecipitation 
  Whole cell lysates were prepared in RIPA buffer (50 mM Tris-HCl, pH 7.4, 
150 mM NaCl, 1% NP-40, 0.25% sodium deoxycholate, 0.1% SDS, 
0.5 mM EDTA, 1 mM EGTA, and 1 mM DTT) plus protease inhibitor (from 
Sigma-Aldrich). Total protein was resolved by SDS-PAGE, transferred onto 
polyvinylidene ﬂ  uoride membranes, blocked in 5% nonfat dry milk/TBST 
(20 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 0.05% Tween 20), and 
  incubated with primary antibodies overnight at 4  °  C. Membranes were 
washed 3  ×   for 10 min in TBST and incubated with HRP-conjugated second-
ary antibodies for 2 h at room temperature. After three 10-min washings, 
membranes were incubated with ECL reagent or Femto Max Sensitivity 
Substrate (Thermo Fisher Scientiﬁ  c) and exposed to x-ray ﬁ  lms. 
to cause localized retraction of axons during neuronal path fi  nd-
ing, but not enough to induce the detachment of cancer cells. 
Our results also call for a reexamination of previous studies on 
the effects of Eph receptors, because the presence or absence of 
serum may have contributed to the varying biological effects 
that have been attributed to Eph receptor activation in cell culture –
 based  experiments. 
  Implications on the role of Abl kinase in cell 
migration and tumor metastasis 
 The Abl protein contains an F-actin binding domain ( McWhirter 
and Wang, 1993  ;   Hantschel et al., 2005  ), and the activated Abl 
kinase can stimulate actin polymerization (  Woodring et al., 
2003  ). Activation of Abl upon cell adhesion to fi  bronectin stim-
ulates the formation of F-actin microspikes (  Woodring et al., 
2002  ,   2003  ) and the dorsal sequestration of Rac-GTP (  Jin and 
Wang, 2007  ). Activation of Abl by growth factors stimulates 
the formation of membrane ruffl  es (  Plattner et al., 1999  ;   Sini et al., 
2004  ), and activation of Abl by bacterial pathogens promotes 
their uptake, a process that requires the host cellular F-actin 
(  Burton et al., 2003  ,   2005  ;   Swimm et al., 2004  ). Although actin 
polymerization drives the forward movement of a migrating 
cell through lamellipodia extension at the front end, the exist-
ing data do not support a role for Abl in the stimulation of cell 
migration. On the contrary, Abl kinase inhibits cell migration 
stimulated by growth factors (  Frasca et al., 2001  ;   Kain and 
Klemke, 2001  ); it also inhibits cell spreading stimulated by fi  bro-
nectin (  Jin and Wang, 2007  ). In our previous study on the role 
of Abl during cell spreading, we found that the Abl kinase ac-
tivity does not affect cell adhesion to fi  bronectin in fi  broblasts 
(  Jin and Wang, 2007  ). Consistent with those results, we found 
that the cellular Rap1-GTP levels were not affected during 
fi  broblast spreading on fi  bronectin, either in the absence or the 
presence of Abl (Fig. S1 B). Instead, we have previously shown 
that Abl-dependent CrkII phosphorylation is involved in the 
dorsal sequestration of Rac-GTP during fi  broblast spreading 
on fi  bronectin (  Jin and Wang, 2007  ). Furthermore, although   Kain 
and  Klemke   ( 2001 )  have  shown  Abl-dependent  CrkII  phos-
phorylation reduces the levels of Rac-GTP in transient trans-
fection experiments, we did not observe any reduction in Rac-GTP 
levels after the induced expression of AblPP in HEK293 cells 
(  Fig. 5 C  ). Together, results from this and previous studies sug-
gest that the Abl  –  CrkII signaling module can exert different 
downstream effects on Rac-GTP or Rap1-GTP. The biological 
output from Abl – CrkII appears to be modulated by the upstream 
signals, i.e., growth factors versus ephrins versus fi  bronectin, 
as well as by the type of cells in which the Abl  –  CrkII module 
is activated. 
  Previous research has shown that the Abl  –  CrkII pathway 
is activated by Eph family of receptor tyrosine kinases, which 
regulate axon guidance, angiogenesis, and tissue patterning during 
embryonic development (  Kullander and Klein, 2002  ;   Pasquale, 
2005  ;   Pasquale, 2008  ). Recently, Eph receptors are also shown 
to be involved in tumor development, with either positive or 
negative effects on the tumor metastatic potential (  Kinch et al., 
2003  ;   Miyazaki et al., 2003  ;   Brantley-Sieders et al., 2004  ;   Saito 
et al., 2004  ;   Noren et al., 2006  ;   Pasquale, 2008  ). The negative 721 ABI-DEPENDENT DOWN-REGULATION OF RAP1-GTP   • Huang et al. 
  Online supplemental material 
  Fig. S1 A shows the detection of CrkII  –  C3G complex before the induction 
of AblPP and the formation of an alternate CrkII  –  AblPP complex after the 
induction of AblPP in the HEK293-AblPP cells. Fig. S1 B shows that Rap1-
GTP levels were not signiﬁ  cantly altered during mouse embryo ﬁ  broblast 
spreading on ﬁ  bronectin. The levels of Rap1-GTP were examined in embryo 
ﬁ  broblasts derived from the   Abl 
    /     Arg 
    /        mouse and those reconstituted for 
Abl expression using retroviral-mediated gene transfer. This result is consis-
tent with previous ﬁ  ndings that Abl does not affect the adhesion of mouse 
embryo ﬁ  broblasts to ﬁ  bronectin. The online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.200801192/DC1. 
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